Search clinical trials for: Androgen-Resistant Prostatic Neoplasms

Total 108218 results

MacroGenics

Recruiting

A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer

Prostate Cancer Recurrent | Immunotherapy | Androgen-Independent Prostatic Cancer | Androgen-Resistant Prostatic Cancer | Hormone Refractory Prostatic Cancer | Immune Checkpoint Inhibitor | Androgen-Independent Prostatic Neoplasms | Androgen-Insensitive Prostatic Cance | Inhibitory Checkpoint Molecule

United States, Spain, France, Belgium, United Kingdom, Poland, Georgia, Bulgaria, Puerto Rico, Australia
Endocyte

Recruiting

Study of 225Ac-PSMA-617 in Men With PSMA-positive Prostate Cancer

Prostatic Neoplasms, Castration-Resistant

Australia, South Africa
Arcus Biosciences, Inc.
Gilead Sciences

Active, not recruiting

Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer (ARC-6)

Prostatic Neoplasms, Castration-Resistant | Prostatic Cancer, Castration-Resistant | Castration Resistant Prostatic Neoplasms | Androgen-Resistant Prostatic Neoplasms

United States, Canada
MacroGenics

Active, not recruiting

A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors (Tamarack)

Melanoma | Non-small Cell Lung Cancer | Small-cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Anal Cancer | Malignant Melanoma | Non-small Cell Carcinoma | Oral Squamous Cell Carcinoma | Small Cell Carcinoma | Laryngeal Squamous Cell Carcinoma | Carcinoma, Squamous Cell of Head and Neck | Castration-Resistant... and other conditions

Spain, Australia, United States, Korea, Republic of, France, United Kingdom, Italy, Belgium, Poland
Veru Inc.

Terminated

Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting Agent (VERACITY)

Metastatic Castration-resistant Prostate Cancer | Androgen Resistant Prostatic Cancer

United States
Memorial Sloan Kettering Cancer Center
TransThera Sciences

Recruiting

A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer

Prostate Cancer

United States
AstraZeneca

Not yet recruiting

Real-life Experience in Brazil in Patients With Castration-resistant Prostate Cancer Treated With Olaparib+Abiraterone (PROCeed-BR)

Prostatic Neoplasms

Brazil
Imperial College London

Not yet recruiting

Comparing pOrtable MRI and TRUS-Fusion Prostate Biopsy to Assess aCcuracy of Prostate Cancer Detection (IP10-COMPACT)

Prostate Cancer

United Kingdom
Boston Scientific Corporation

Not yet recruiting

SpaceIT Hydrogel System for Perirectal Spacing (HYDROSPACE)

Prostate Cancer
Astellas Pharma Korea, Inc.

Not yet recruiting

Non-Interventional Study to Establish Consensus on Management of Metastatic Hormone-Sensitive Prostate Cancer Patients

Metastatic Hormone-Sensitive Prostate Cancer
University Health Network, Toronto

Recruiting

A Pan-Canadian, Investigator Initiated Clinical Trial With Focal IRE Directed to Intermediate-Risk Prostate Cancer (WIRED)

Prostate Cancer

Canada
Centre Henri Becquerel

Not yet recruiting

Dynamic 68Ga-PSMA and 18F-FDG PET/CT Analysis Prior to 177Lu-PSMA (PYPET)

Prostate Cancer Metastatic

France
Maria Sklodowska-Curie National Research Institute...

Not yet recruiting

177Lu-PSMA as a Systemic Adjuvant Treatment in Patients With High and Very High Risk Prostate Cancer (PSMA-ADJUVO)

Prostate Cancer
SURGE Therapeutics

Not yet recruiting

Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy

Prostate Cancer
The Swedish School of Sport and Health Sciences
Karolinska Institutet; Sahlgrenska University Hospital, Sweden; Prostate Cancer... and other collaborators

Recruiting

Training for Men Undergoing Androgen Deprivation Therapy. (ADT-train)

Prostate Cancer

Sweden
University of California, Irvine

Not yet recruiting

Relationship bw Image-deriv Features of Intraoperative ICG Visualiz of NVBs During RARP & Functional Outcome

Prostate Adenocarcinoma

United States
Uppsala University
Sahlgrenska University Hospital, Sweden; University Hospital, Umeå; Uppsala University... and other collaborators

Not yet recruiting

The Case of "Triple" Versus "Double" Therapy for Patients With High Volume Metastatic Hormone Sensitive Prostate Cancer (Lead4Care)

Prostate Cancer

Sweden
Mayo Clinic

Not yet recruiting

An Investigational Scan (Ga-68 PSMA-11 PET/CT) for Detection of Disease Recurrence or Progression in Patients With Glioma

WHO Grade 3 Glioma | WHO Grade 2 Glioma | WHO Grade 4 Glioma

United States
Osaka University
Japan Agency for Medical Research and Development

Recruiting

Clinical Trial of Targeted Alpha Therapy for Prostate Cancer (Alpha-PS1)

Prostate Cancer

Japan
Shanghai East Hospital

Not yet recruiting

Multi-Modal Image Fusion for Precision Prostate Biopsy Navigation

Prostate Cancer

China
Centre Henri Becquerel

Not yet recruiting

Contribution of the VERITON-CT Camera in Prostate Bone Radiostereotaxy (VERIOS)

Prostatic Cancer

France
Canadian Cancer Trials Group
Canadian Institutes of Health Research (CIHR)

Not yet recruiting

Platinum and Taxane Chemo in Met Castration Resistant Prostate Cancer Patients With Alterations in DNA Damage Response Genes (OPTION-DDR)

Metastatic Prostate Cancer | Metastatic Castration-resistant Prostate Cancer
Cedars-Sinai Medical Center
National Cancer Institute (NCI)

Not yet recruiting

Intensive Cholesterol-Lowering and CD8+ T Cells in Prostate Cancer

Prostate Cancer
First Affiliated Hospital of Fujian Medical University

Recruiting

68Ga-AAZTA-093 PET/CT: First-in-human Study

Malignant Neoplasm of Prostate

China
Peking University Third Hospital
Bayer

Not yet recruiting

Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy in Prostate Cancer Patients With Lymph Node-positive After Radical Prostatectomy: A Prospective Observational Cohort Study

Prostate Cancer

China
Ning Xu
The First Affiliated Hospital of Nanchang University; Zhongshan Hospital Xiamen... and other collaborators

Not yet recruiting

Posterior Extra-fascial RARP in Intermediate or High Risk Prostate Cancer

Prostate Cancer | Surgical Procedure, Unspecified
Case Comprehensive Cancer Center

Not yet recruiting

Developing Inclusive Support and Intervention for Spanish-speaking Latiné Prostate Cancer Survivors

Prostate Cancer

United States
Institut de Cancérologie de Lorraine

Recruiting

Adherence to Oral Therapies in Advanced Breast and Prostate Cancers (AdOTAC)

Breast Cancer | Prostate Cancer

France
Clinton Bahler
On Target Laboratories

Not yet recruiting

CYTALUX™for the Intraoperative Imaging of Prostate Cancer

Prostate Cancer

United States
Cigdem Soydal

Recruiting

Effect of Hypoxia on FMISO PET to Response to Lu-177 PSMA Treatment (LuMISO)

Hypoxia | Prostatic Neoplasms

Turkey
Medical University of Vienna
Lund University; Ziekenhuis Netwerk Antwerpen (ZNA); St. Antonius Hospital; Azienda... and other collaborators

Not yet recruiting

Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study (OLIGOMET)

Prostate Cancer | Prostate Cancer Metastatic | Oligometastasis | Prostate Neoplasm | Oligometastatic Disease | Prostate Cancer Metastatic to Bone
Paul Viscuse

Not yet recruiting

Remotely Monitored Exercise Interventions in Patients With mCSPC Undergoing ADT (Prostate 006)

Metastatic Prostate Cancer | Castrate Sensitive Prostate Cancer

United States
Osamu Ukimura

Recruiting

Targeted Microwave Tissue Coagulation for Prostate Cancer (MicroPro2)

Prostate Cancer

Japan
European Association of Urology Research Foundation
National Cancer Institute (NCI); UMC Utrecht; Erasmus Medical Center; University... and other collaborators

Not yet recruiting

Prostate Cancer Awareness and Initiative for Screening in the European Union (PRAISE-U)

Prostate Cancer
Institute of Cancer Research, United Kingdom

Recruiting

Microbiome Molecular Charaterisation (MMC)

Prostate Cancer

United Kingdom
University of Southern California
National Cancer Institute (NCI)

Not yet recruiting

Access to Genetic Testing in Underserved Patients With Cancer

Malignant Solid Neoplasm | Breast Carcinoma | Metastatic Prostate Carcinoma | Ovarian Carcinoma | Triple-Negative Breast Carcinoma | Male Breast Carcinoma | Pancreatic Exocrine Neoplasm | Stage IVB Prostate Cancer American Joint Committee on Cancer v8

United States
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Not yet recruiting

M9466 as Single Agent or in Combination With Tuvusertib in Advanced Solid Tumors (DDRiver 501)

Advanced Solid Tumor

United States, Germany
First Affiliated Hospital of Chongqing Medical...

Recruiting

99mTc-QULIC-5-P1 SPECT Imaging in Patients With Prostate Cancer

PSMA | Prostate Cancer Stage | SPECT

China
University Hospital Padova

Recruiting

Can Needle Size Improve Cancer Detection Rate of Transperineal MRI Target Prostate Biopsy Without Affecting Side Effects? (TARGET)

Prostate Cancer Diagnosis

Italy
University Health Network, Toronto

Not yet recruiting

Adaptive Moderately Hypofractionated Post Operative Radiotherapy (AMPORA)

Post-Operative Prostate Cancer
Lionel.D.Lewis, MD
Dartmouth Cancer Center

Not yet recruiting

HCQ in Resectable Localized Prostate Cancer

Resectable Localized Prostate Cancer
Maastricht University Medical Center
Jessa Hospital

Not yet recruiting

The Impact of Physical Activity Versus Dietary Energy Restriction on Tumour and Muscle Protein Synthesis in Prostate Cancer Patients (DIRECT)

Cancer of Prostate
Swiss Group for Clinical Cancer Research

Not yet recruiting

Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Metastatic Castration-resistant Prostate Cancer

Switzerland
University of Florida
EDAP-TMS Focal One

Not yet recruiting

High Intensity Focused Ultrasound in Prostate Cancer

Prostate Cancer

United States
Chang Gung Memorial Hospital

Recruiting

Comparing Bp-MRI and Mp-MRI for Prostate Cancer Screening Accuracy

Prostate Cancer | Magnetic Resonance Imaging | Randomized Controlled Trial

Taiwan
Fusion Pharmaceuticals Inc.

Recruiting

FPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) (AlphaBreak)

Metastatic Castration-resistant Prostate Cancer

United States
IRCCS San Raffaele

Recruiting

Observational Study of Patients Who Underwent Diagnostic Investigation (Prostate Biopsy) and/or Radical Prostatectomy Surgery.

Prostate Cancer

Italy
Oslo University Hospital
University Hospital, Akershus

Recruiting

Preoperative PSMA PET/CT as Triage for ePLND in Patients Scheduled for RALP (PrePSMA) (PrePSMA)

Prostate Cancer

Norway
University College, London
University College London Hospitals

Recruiting

Study to Evaluate a New Method to Detect Residual Tumours During Surgery for Prostate Cancer Using Confocal Microscopy

Prostate Cancer

United Kingdom
NYU Langone Health

Recruiting

ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer

Prostate Cancer

United States

Search clinical trials for: Androgen-Resistant Prostatic Neoplasms

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Turkmenistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations